http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2017276835-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71902e53dae946ec51814b9c4679b555
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
filingDate 2017-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca36e25b895212559b08c9b3ebc86383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_326c040986d3a406891d75430946bd25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_114899353a8be43c03de045a3f0c9e08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8bab74ac90f9c3e0577e3107d4672dd
publicationDate 2022-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2017276835-B2
titleOfInvention Methods for treating heterotopic ossification
abstract The invention features dosing regimens and pharmaceutical formulations for oral administration of palovarotene. The dosing regimens can reduce heterotopic ossification, reduce the number of flare- ups, and/or reduce the severity of flare-ups in subjects suffering from fibrodysplasia ossificans progressiva.
priorityDate 2016-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID685072
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF1PN60
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A286ZM53
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP28699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426369380
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414871259
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6VXM9
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430777503
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12629
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2760897
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86275250
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10295295
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410531777
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18677595
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID540425
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11477
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID947861
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141699235
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID451935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11524144
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A5F4D9R6
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397983
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60182388
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424858772
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16134267
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50997747
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454269980
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP18516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424307695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413872206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424505814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454406839
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID90
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5916
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID486508
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID30615
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP18911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410916410

Total number of triples: 73.